posted on 2024-12-03, 11:22authored byAline R Pavan, Joshua P Smalley, Urvashi Patel, Wiktoria A Pytel, Jean Leandro dos Santos, Shaun M Cowley, John WR Schwabe, James HodgkinsonJames Hodgkinson
Histone deacetylase (HDAC) enzymes 1–3 exist in several corepressor complexes and are viable drug targets. To date, proteolysis targeting chimeras (PROTACs) designed to target HDAC1–3 typically exhibit the selective degradation of HDAC3. Herein, we report cereblon-recruiting PROTACs that degrade HDAC1 with selectivity over HDAC3.